Publication: Taste-immune associative learning amplifies immunopharmacological effects and attenuates disease progression in a rat glioblastoma model
Taste-immune associative learning amplifies immunopharmacological effects and attenuates disease progression in a rat glioblastoma model
Date
Date
Date
Citations
Hetze, S., Barthel, L., Lückemann, L., Günther, H. S., Wülfing, C., Salem, Y., Jakobs, M., Hörbelt-Grünheidt, T., Petschulat, J., Bendix, I., Weber-Stadlbauer, U., Sure, U., Schedlowski, M., & Hadamitzky, M. (2022). Taste-immune associative learning amplifies immunopharmacological effects and attenuates disease progression in a rat glioblastoma model. Brain, Behavior, and Immunity, 106, 270–279. https://doi.org/10.1016/j.bbi.2022.09.006
Abstract
Abstract
Abstract
Mechanistic target of rapamycin (mTOR)-signaling is one key driver of glioblastoma (GBM), facilitating tumor growth by promoting the shift to an anti-inflammatory, pro-cancerogenic microenvironment. Even though mTOR inhibitors such as rapamycin (RAPA) have been shown to interfere with GBM disease progression, frequently chaperoned toxic drug side effects urge the need for developing alternative or supportive treatment strategies. Importantly, previous work document that taste-immune associative learning with RAPA may be utilized to in
Additional indexing
Creators (Authors)
Volume
Volume
Volume
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
Keywords
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Publisher DOI
Citations
Hetze, S., Barthel, L., Lückemann, L., Günther, H. S., Wülfing, C., Salem, Y., Jakobs, M., Hörbelt-Grünheidt, T., Petschulat, J., Bendix, I., Weber-Stadlbauer, U., Sure, U., Schedlowski, M., & Hadamitzky, M. (2022). Taste-immune associative learning amplifies immunopharmacological effects and attenuates disease progression in a rat glioblastoma model. Brain, Behavior, and Immunity, 106, 270–279. https://doi.org/10.1016/j.bbi.2022.09.006